Novo Nordisk ADR (NYSE: NVO) is -25.17% lower on its value in year-to-date trading and has touched a low of $57.00 and a high of $148.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVO stock was last observed hovering at around $66.15 in the last trading session, with the day’s loss setting it -1.78%.
Currently trading at $64.37, the stock is -0.58% and -6.06% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 19.0 million and changing -2.69% at the moment leaves the stock -34.56% off its SMA200. NVO registered -51.57% loss for a year compared to 6-month loss of -39.87%.
The stock witnessed a 2.37% gain in the last 1 month and extending the period to 3 months gives it a -17.34%, and is -2.13% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.50% over the week and 2.99% over the month.
Novo Nordisk ADR (NVO) has around 76302 employees, a market worth around $216.68B and $43.59B in sales. Current P/E ratio is 19.09 and Fwd P/E is 13.63. Profit margin for the company is 34.52%. Distance from 52-week low is 12.93% and -56.55% from its 52-week high. The company has generated returns on investments over the last 12 months (44.25%).
with sales reaching $77.83B over the same period.The EPS is expected to grow by 25.93% this year, but quarterly earnings will post 15.85% year-over-year. Quarterly sales are estimated to grow 14.35% in year-over-year returns.
Novo Nordisk ADR (NVO) Top Institutional Holders
The shares outstanding are 3.37B, and float is at 3.37B with Short Float at 0.75%.
The top institutional shareholder in the company is JENNISON ASSOCIATES LLC with over 21.22 million shares valued at $3.03 billion. The investor’s holdings represent 0.476% of the NVO Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 19.49 million shares valued at $2.78 billion to account for 0.4373 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 14.61 million shares representing 0.3278% and valued at over $2.09 billion, while BANK OF AMERICA CORP /DE/ holds 0.3183 of the shares totaling 14.19 million with a market value of $2.03 billion.
Novo Nordisk ADR (NVO) Insider Activity
#####
